|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.01.26 - 04:24
|
Akeso Confident of Cancer Drug′s FDA Approval Odds (Bloomberg)
|
|
|
Chinese biopharmaceutical firm Akeso's CFO, Bing Wang, says he feels “pretty good” about the chances of receiving approval from US regulators for ivonescimab, the company's key cancer drug developed in partnership with US-based Summit Therapeutics. Wang speaks exclusively on Bloomberg: The China Show from San Francisco, where the marquee industry event hosted by JPMorgan is taking place. (Source: Bloomberg)...
|
|
|
16.01.26 - 01:51
|
JPMorganChase Declares Preferred Stock Dividends (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm's Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news.
JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $362 billion in stockholders' equity as of December 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world's most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganc...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
